The Changing Epidemiology of Inflammatory Bowel Disease: What Goes Up May Come Down
- PMID: 31504537
- PMCID: PMC7056818
- DOI: 10.1093/ibd/izz186
The Changing Epidemiology of Inflammatory Bowel Disease: What Goes Up May Come Down
Abstract
Recent epidemiologic studies have shown that although the incidence of inflammatory bowel disease (IBD) is rapidly increasing in newly industrialized countries, at the turn of the 21st century the incidence had stabilized in the Western world. In this issue of Inflammatory Bowel Diseases, Torabi and colleagues present their findings on the temporal trends and geographic variations in IBD incidence in Manitoba from 1990 to 2012 using the Manitoba Health population registry and the University of Manitoba IBD epidemiology database. Their results demonstrate an overall decrease in the incidence of IBD during the study period. They also found significant regional variations in disease incidence within Manitoba, with rates of new diagnosis of IBD remaining high in several regions. Lastly, the study found that a higher proportion of the indigenous population had a lower rate of IBD. These findings provide new insights on the changing epidemiology of IBD in the Western world. The overall declining incidence of IBD and identification of persistently low and high-risk populations in Manitoba, which traditionally has had some of the highest incidence rates of IBD, is intriguing and can provide new avenues of research for epidemiologists in the field.
Keywords: Crohn’s disease; epidemiology; inflammatory bowel disease; time trend; ulcerative colitis.
© 2019 Crohn’s & Colitis Foundation. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Comment on
-
Geographical Variation and Factors Associated With Inflammatory Bowel Disease in a Central Canadian Province.Inflamm Bowel Dis. 2020 Mar 4;26(4):581-590. doi: 10.1093/ibd/izz168. Inflamm Bowel Dis. 2020. PMID: 31504519
Similar articles
-
The Impact of Inflammatory Bowel Disease in Canada 2018: Epidemiology.J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S6-S16. doi: 10.1093/jcag/gwy054. Epub 2018 Nov 2. J Can Assoc Gastroenterol. 2019. PMID: 31294381 Free PMC article.
-
Geographical Variation and Factors Associated With Inflammatory Bowel Disease in a Central Canadian Province.Inflamm Bowel Dis. 2020 Mar 4;26(4):581-590. doi: 10.1093/ibd/izz168. Inflamm Bowel Dis. 2020. PMID: 31504519
-
The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S17-S33. doi: 10.1093/jcag/gwy055. Epub 2018 Nov 2. J Can Assoc Gastroenterol. 2019. PMID: 31294382 Free PMC article.
-
Implications of the changing epidemiology of inflammatory bowel disease in a changing world.United European Gastroenterol J. 2022 Dec;10(10):1113-1120. doi: 10.1002/ueg2.12317. Epub 2022 Oct 17. United European Gastroenterol J. 2022. PMID: 36251359 Free PMC article. Review.
-
Twenty-first Century Trends in the Global Epidemiology of Pediatric-Onset Inflammatory Bowel Disease: Systematic Review.Gastroenterology. 2022 Apr;162(4):1147-1159.e4. doi: 10.1053/j.gastro.2021.12.282. Epub 2022 Jan 5. Gastroenterology. 2022. PMID: 34995526
Cited by
-
Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019: a systematic analysis based on the Global Burden of Disease Study 2019.BMJ Open. 2023 Mar 28;13(3):e065186. doi: 10.1136/bmjopen-2022-065186. BMJ Open. 2023. PMID: 36977543 Free PMC article. Review.
-
Coping Strategies and Inflammatory Bowel Disease: A Narrative Review.J Clin Med. 2024 Mar 12;13(6):1630. doi: 10.3390/jcm13061630. J Clin Med. 2024. PMID: 38541856 Free PMC article. Review.
-
The Role of Viruses in the Pathogenesis of Immune-Mediated Gastro-Intestinal Diseases.Int J Mol Sci. 2024 Jul 30;25(15):8301. doi: 10.3390/ijms25158301. Int J Mol Sci. 2024. PMID: 39125870 Free PMC article. Review.
-
From west to east: dissecting the global shift in inflammatory bowel disease burden and projecting future scenarios.BMC Public Health. 2025 Aug 7;25(1):2696. doi: 10.1186/s12889-025-24009-z. BMC Public Health. 2025. PMID: 40775705 Free PMC article.
-
TLR4 promoted endoplasmic reticulum stress induced inflammatory bowel disease via the activation of p38 MAPK pathway.Biosci Rep. 2022 Apr 29;42(4):BSR20220307. doi: 10.1042/BSR20220307. Biosci Rep. 2022. PMID: 35352794 Free PMC article.
References
-
- Ng SC, Shi HY, Hamidi N, et al. . Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2018;390:2769–2778. - PubMed
-
- Torabi M, Bernstein CN, Yu BN, et al. . Geographical variation and factors associated with inflammatory bowel disease in a central Canadian province. Inflammat Bowel Dis. 2020;26:581–590. - PubMed